Table of Content

1 Active Transdermal Drug Delivery Device Market Overview
1.1 Active Transdermal Drug Delivery Device Product Scope
1.2 Active Transdermal Drug Delivery Device Segment by Type
1.2.1 Global Active Transdermal Drug Delivery Device Sales by Type (2016 & 2021 & 2027)
1.2.2 Patches
1.2.3 Gels
1.3 Active Transdermal Drug Delivery Device Segment by Application
1.3.1 Global Active Transdermal Drug Delivery Device Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Home Use
1.4 Active Transdermal Drug Delivery Device Market Estimates and Forecasts (2016-2027)
1.4.1 Global Active Transdermal Drug Delivery Device Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Active Transdermal Drug Delivery Device Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Active Transdermal Drug Delivery Device Price Trends (2016-2027)

2 Active Transdermal Drug Delivery Device Estimates and Forecasts by Region
2.1 Global Active Transdermal Drug Delivery Device Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Active Transdermal Drug Delivery Device Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Active Transdermal Drug Delivery Device Sales Market Share by Region (2016-2021)
2.2.2 Global Active Transdermal Drug Delivery Device Revenue Market Share by Region (2016-2021)
2.3 Global Active Transdermal Drug Delivery Device Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Active Transdermal Drug Delivery Device Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Active Transdermal Drug Delivery Device Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Active Transdermal Drug Delivery Device Estimates and Projections (2016-2027)
2.4.2 Europe Active Transdermal Drug Delivery Device Estimates and Projections (2016-2027)
2.4.3 China Active Transdermal Drug Delivery Device Estimates and Projections (2016-2027)
2.4.4 Japan Active Transdermal Drug Delivery Device Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Active Transdermal Drug Delivery Device Estimates and Projections (2016-2027)
2.4.6 India Active Transdermal Drug Delivery Device Estimates and Projections (2016-2027)

3 Global Active Transdermal Drug Delivery Device Competition Landscape by Players
3.1 Global Top Active Transdermal Drug Delivery Device Players by Sales (2016-2021)
3.2 Global Top Active Transdermal Drug Delivery Device Players by Revenue (2016-2021)
3.3 Global Active Transdermal Drug Delivery Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Active Transdermal Drug Delivery Device as of 2020)
3.4 Global Active Transdermal Drug Delivery Device Average Price by Company (2016-2021)
3.5 Manufacturers Active Transdermal Drug Delivery Device Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Active Transdermal Drug Delivery Device Market Size by Type
4.1 Global Active Transdermal Drug Delivery Device Historic Market Review by Type (2016-2021)
4.1.1 Global Active Transdermal Drug Delivery Device Sales Market Share by Type (2016-2021)
4.1.2 Global Active Transdermal Drug Delivery Device Revenue Market Share by Type (2016-2021)
4.1.3 Global Active Transdermal Drug Delivery Device Price by Type (2016-2021)
4.2 Global Active Transdermal Drug Delivery Device Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Active Transdermal Drug Delivery Device Sales Forecast by Type (2022-2027)
4.2.2 Global Active Transdermal Drug Delivery Device Revenue Forecast by Type (2022-2027)
4.2.3 Global Active Transdermal Drug Delivery Device Price Forecast by Type (2022-2027)

5 Global Active Transdermal Drug Delivery Device Market Size by Application
5.1 Global Active Transdermal Drug Delivery Device Historic Market Review by Application (2016-2021)
5.1.1 Global Active Transdermal Drug Delivery Device Sales Market Share by Application (2016-2021)
5.1.2 Global Active Transdermal Drug Delivery Device Revenue Market Share by Application (2016-2021)
5.1.3 Global Active Transdermal Drug Delivery Device Price by Application (2016-2021)
5.2 Global Active Transdermal Drug Delivery Device Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Active Transdermal Drug Delivery Device Sales Forecast by Application (2022-2027)
5.2.2 Global Active Transdermal Drug Delivery Device Revenue Forecast by Application (2022-2027)
5.2.3 Global Active Transdermal Drug Delivery Device Price Forecast by Application (2022-2027)

6 North America Active Transdermal Drug Delivery Device Market Facts & Figures
6.1 North America Active Transdermal Drug Delivery Device Sales by Company
6.1.1 North America Active Transdermal Drug Delivery Device Sales by Company (2016-2021)
6.1.2 North America Active Transdermal Drug Delivery Device Revenue by Company (2016-2021)
6.2 North America Active Transdermal Drug Delivery Device Sales Breakdown by Type
6.2.1 North America Active Transdermal Drug Delivery Device Sales Breakdown by Type (2016-2021)
6.2.2 North America Active Transdermal Drug Delivery Device Sales Breakdown by Type (2022-2027)
6.3 North America Active Transdermal Drug Delivery Device Sales Breakdown by Application
6.3.1 North America Active Transdermal Drug Delivery Device Sales Breakdown by Application (2016-2021)
6.3.2 North America Active Transdermal Drug Delivery Device Sales Breakdown by Application (2022-2027)

7 Europe Active Transdermal Drug Delivery Device Market Facts & Figures
7.1 Europe Active Transdermal Drug Delivery Device Sales by Company
7.1.1 Europe Active Transdermal Drug Delivery Device Sales by Company (2016-2021)
7.1.2 Europe Active Transdermal Drug Delivery Device Revenue by Company (2016-2021)
7.2 Europe Active Transdermal Drug Delivery Device Sales Breakdown by Type
7.2.1 Europe Active Transdermal Drug Delivery Device Sales Breakdown by Type (2016-2021)
7.2.2 Europe Active Transdermal Drug Delivery Device Sales Breakdown by Type (2022-2027)
7.3 Europe Active Transdermal Drug Delivery Device Sales Breakdown by Application
7.3.1 Europe 128 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 128 Sales Breakdown by Application (2022-2027)

8 China Active Transdermal Drug Delivery Device Market Facts & Figures
8.1 China Active Transdermal Drug Delivery Device Sales by Company
8.1.1 China Active Transdermal Drug Delivery Device Sales by Company (2016-2021)
8.1.2 China Active Transdermal Drug Delivery Device Revenue by Company (2016-2021)
8.2 China Active Transdermal Drug Delivery Device Sales Breakdown by Type
8.2.1 China Active Transdermal Drug Delivery Device Sales Breakdown by Type (2016-2021)
8.2.2 China Active Transdermal Drug Delivery Device Sales Breakdown by Type (2022-2027)
8.3 China Active Transdermal Drug Delivery Device Sales Breakdown by Application
8.3.1 China 155 Sales Breakdown by Application (2016-2021)
8.3.2 China 155 Sales Breakdown by Application (2022-2027)

9 Japan Active Transdermal Drug Delivery Device Market Facts & Figures
9.1 Japan Active Transdermal Drug Delivery Device Sales by Company
9.1.1 Japan Active Transdermal Drug Delivery Device Sales by Company (2016-2021)
9.1.2 Japan Active Transdermal Drug Delivery Device Revenue by Company (2016-2021)
9.2 Japan Active Transdermal Drug Delivery Device Sales Breakdown by Type
9.2.1 Japan Active Transdermal Drug Delivery Device Sales Breakdown by Type (2016-2021)
9.2.2 Japan Active Transdermal Drug Delivery Device Sales Breakdown by Type (2022-2027)
9.3 Japan Active Transdermal Drug Delivery Device Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Active Transdermal Drug Delivery Device Market Facts & Figures
10.1 Southeast Asia Active Transdermal Drug Delivery Device Sales by Company
10.1.1 Southeast Asia Active Transdermal Drug Delivery Device Sales by Company (2016-2021)
10.1.2 Southeast Asia Active Transdermal Drug Delivery Device Revenue by Company (2016-2021)
10.2 Southeast Asia Active Transdermal Drug Delivery Device Sales Breakdown by Type
10.2.1 Southeast Asia Active Transdermal Drug Delivery Device Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Active Transdermal Drug Delivery Device Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Active Transdermal Drug Delivery Device Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Active Transdermal Drug Delivery Device Market Facts & Figures
11.1 India Active Transdermal Drug Delivery Device Sales by Company
11.1.1 India Active Transdermal Drug Delivery Device Sales by Company (2016-2021)
11.1.2 India Active Transdermal Drug Delivery Device Revenue by Company (2016-2021)
11.2 India Active Transdermal Drug Delivery Device Sales Breakdown by Type
11.2.1 India Active Transdermal Drug Delivery Device Sales Breakdown by Type (2016-2021)
11.2.2 India Active Transdermal Drug Delivery Device Sales Breakdown by Type (2022-2027)
11.3 India Active Transdermal Drug Delivery Device Sales Breakdown by Application
11.3.1 India Active Transdermal Drug Delivery Device Sales Breakdown by Application (2016-2021)
11.3.2 India Active Transdermal Drug Delivery Device Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Active Transdermal Drug Delivery Device Business
12.1 Novartis AG
12.1.1 Novartis AG Corporation Information
12.1.2 Novartis AG Business Overview
12.1.3 Novartis AG Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Novartis AG Active Transdermal Drug Delivery Device Products Offered
12.1.5 Novartis AG Recent Development
12.2 Noven Pharmaceuticals, Inc.
12.2.1 Noven Pharmaceuticals, Inc. Corporation Information
12.2.2 Noven Pharmaceuticals, Inc. Business Overview
12.2.3 Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Products Offered
12.2.5 Noven Pharmaceuticals, Inc. Recent Development
12.3 Transdermal Corp.
12.3.1 Transdermal Corp. Corporation Information
12.3.2 Transdermal Corp. Business Overview
12.3.3 Transdermal Corp. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Transdermal Corp. Active Transdermal Drug Delivery Device Products Offered
12.3.5 Transdermal Corp. Recent Development
12.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.)
12.4.1 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Corporation Information
12.4.2 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Business Overview
12.4.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Products Offered
12.4.5 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Recent Development
12.5 Mylan N.V.
12.5.1 Mylan N.V. Corporation Information
12.5.2 Mylan N.V. Business Overview
12.5.3 Mylan N.V. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Mylan N.V. Active Transdermal Drug Delivery Device Products Offered
12.5.5 Mylan N.V. Recent Development
12.6 3M
12.6.1 3M Corporation Information
12.6.2 3M Business Overview
12.6.3 3M Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2016-2021)
12.6.4 3M Active Transdermal Drug Delivery Device Products Offered
12.6.5 3M Recent Development
12.7 Actavis, Inc.
12.7.1 Actavis, Inc. Corporation Information
12.7.2 Actavis, Inc. Business Overview
12.7.3 Actavis, Inc. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Actavis, Inc. Active Transdermal Drug Delivery Device Products Offered
12.7.5 Actavis, Inc. Recent Development
12.8 Bayer AG
12.8.1 Bayer AG Corporation Information
12.8.2 Bayer AG Business Overview
12.8.3 Bayer AG Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Bayer AG Active Transdermal Drug Delivery Device Products Offered
12.8.5 Bayer AG Recent Development
12.9 Boehringer Ingelheim GmbH
12.9.1 Boehringer Ingelheim GmbH Corporation Information
12.9.2 Boehringer Ingelheim GmbH Business Overview
12.9.3 Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Products Offered
12.9.5 Boehringer Ingelheim GmbH Recent Development
12.10 Corium International, Inc.
12.10.1 Corium International, Inc. Corporation Information
12.10.2 Corium International, Inc. Business Overview
12.10.3 Corium International, Inc. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Corium International, Inc. Active Transdermal Drug Delivery Device Products Offered
12.10.5 Corium International, Inc. Recent Development
12.11 Echo Therapeutics, Inc.
12.11.1 Echo Therapeutics, Inc. Corporation Information
12.11.2 Echo Therapeutics, Inc. Business Overview
12.11.3 Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Products Offered
12.11.5 Echo Therapeutics, Inc. Recent Development
12.12 GlaxoSmithKline plc
12.12.1 GlaxoSmithKline plc Corporation Information
12.12.2 GlaxoSmithKline plc Business Overview
12.12.3 GlaxoSmithKline plc Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2016-2021)
12.12.4 GlaxoSmithKline plc Active Transdermal Drug Delivery Device Products Offered
12.12.5 GlaxoSmithKline plc Recent Development

13 Active Transdermal Drug Delivery Device Manufacturing Cost Analysis
13.1 Active Transdermal Drug Delivery Device Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Active Transdermal Drug Delivery Device
13.4 Active Transdermal Drug Delivery Device Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Active Transdermal Drug Delivery Device Distributors List
14.3 Active Transdermal Drug Delivery Device Customers

15 Market Dynamics
15.1 Active Transdermal Drug Delivery Device Market Trends
15.2 Active Transdermal Drug Delivery Device Drivers
15.3 Active Transdermal Drug Delivery Device Market Challenges
15.4 Active Transdermal Drug Delivery Device Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Active Transdermal Drug Delivery Device Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Active Transdermal Drug Delivery Device Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Active Transdermal Drug Delivery Device Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Active Transdermal Drug Delivery Device Sales (K Units) by Region (2016-2021)
Table 5. Global Active Transdermal Drug Delivery Device Sales Market Share by Region (2016-2021)
Table 6. Global Active Transdermal Drug Delivery Device Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Active Transdermal Drug Delivery Device Revenue Share by Region (2016-2021)
Table 8. Global Active Transdermal Drug Delivery Device Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Active Transdermal Drug Delivery Device Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Active Transdermal Drug Delivery Device Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Active Transdermal Drug Delivery Device Revenue Share Forecast by Region (2022-2027)
Table 12. Global Active Transdermal Drug Delivery Device Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Active Transdermal Drug Delivery Device Sales Share by Company (2016-2021)
Table 14. Global Active Transdermal Drug Delivery Device Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Active Transdermal Drug Delivery Device Revenue Share by Company (2016-2021)
Table 16. Global Active Transdermal Drug Delivery Device by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Active Transdermal Drug Delivery Device as of 2020)
Table 17. Global Active Transdermal Drug Delivery Device Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Active Transdermal Drug Delivery Device Manufacturing Sites and Area Served
Table 19. Manufacturers Active Transdermal Drug Delivery Device Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Active Transdermal Drug Delivery Device Sales (K Units) by Type (2016-2021)
Table 22. Global Active Transdermal Drug Delivery Device Sales Share by Type (2016-2021)
Table 23. Global Active Transdermal Drug Delivery Device Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Active Transdermal Drug Delivery Device Price (USD/Unit) by Type (2016-2021)
Table 25. Global Active Transdermal Drug Delivery Device Sales Share by Type (2022-2027)
Table 26. Global Active Transdermal Drug Delivery Device Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Active Transdermal Drug Delivery Device Revenue Share by Type (2022-2027)
Table 28. Global Active Transdermal Drug Delivery Device Price (USD/Unit) by Type (2022-2027)
Table 29. Global Active Transdermal Drug Delivery Device Sales (K Units) by Application (2016-2021)
Table 30. Global Active Transdermal Drug Delivery Device Sales Share by Application (2016-2021)
Table 31. Global Active Transdermal Drug Delivery Device Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Active Transdermal Drug Delivery Device Price (USD/Unit) by Application (2016-2021)
Table 33. Global Active Transdermal Drug Delivery Device Sales (K Units) by Application (2022-2027)
Table 34. Global Active Transdermal Drug Delivery Device Sales Share by Application (2022-2027)
Table 35. Global Active Transdermal Drug Delivery Device Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Active Transdermal Drug Delivery Device Revenue Share by Application (2022-2027)
Table 37. Global Active Transdermal Drug Delivery Device Price (USD/Unit) by Application (2022-2027)
Table 38. North America Active Transdermal Drug Delivery Device Sales (K Units) by Company (2016-2021)
Table 39. North America Active Transdermal Drug Delivery Device Sales Market Share by Company (2016-2021)
Table 40. North America Active Transdermal Drug Delivery Device Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Active Transdermal Drug Delivery Device Revenue Market Share by Company (2016-2021)
Table 42. North America Active Transdermal Drug Delivery Device Sales by Type (2016-2021) & (K Units)
Table 43. North America Active Transdermal Drug Delivery Device Sales Market Share by Type (2016-2021)
Table 44. North America Active Transdermal Drug Delivery Device Sales by Type (2022-2027) & (K Units)
Table 45. North America Active Transdermal Drug Delivery Device Sales Market Share by Type (2022-2027)
Table 46. North America Active Transdermal Drug Delivery Device Sales by Application (2016-2021) & (K Units)
Table 47. North America Active Transdermal Drug Delivery Device Sales Market Share by Application (2016-2021)
Table 48. North America Active Transdermal Drug Delivery Device Sales by Application (2022-2027) & (K Units)
Table 49. North America Active Transdermal Drug Delivery Device Sales Market Share by Application (2022-2027)
Table 50. Europe Active Transdermal Drug Delivery Device Sales (K Units) by Company (2016-2021)
Table 51. Europe Active Transdermal Drug Delivery Device Sales Market Share by Company (2016-2021)
Table 52. Europe Active Transdermal Drug Delivery Device Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Active Transdermal Drug Delivery Device Revenue Market Share by Company (2016-2021)
Table 54. Europe Active Transdermal Drug Delivery Device Sales by Type (2016-2021) & (K Units)
Table 55. Europe Active Transdermal Drug Delivery Device Sales Market Share by Type (2016-2021)
Table 56. Europe Active Transdermal Drug Delivery Device Sales by Type (2022-2027) & (K Units)
Table 57. Europe Active Transdermal Drug Delivery Device Sales Market Share by Type (2022-2027)
Table 58. Europe Active Transdermal Drug Delivery Device Sales by Application (2016-2021) & (K Units)
Table 59. Europe Active Transdermal Drug Delivery Device Sales Market Share by Application (2016-2021)
Table 60. Europe Active Transdermal Drug Delivery Device Sales by Application (2022-2027) & (K Units)
Table 61. Europe Active Transdermal Drug Delivery Device Sales Market Share by Application (2022-2027)
Table 62. China Active Transdermal Drug Delivery Device Sales (K Units) by Company (2016-2021)
Table 63. China Active Transdermal Drug Delivery Device Sales Market Share by Company (2016-2021)
Table 64. China Active Transdermal Drug Delivery Device Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Active Transdermal Drug Delivery Device Revenue Market Share by Company (2016-2021)
Table 66. China Active Transdermal Drug Delivery Device Sales by Type (2016-2021) & (K Units)
Table 67. China Active Transdermal Drug Delivery Device Sales Market Share by Type (2016-2021)
Table 68. China Active Transdermal Drug Delivery Device Sales by Type (2022-2027) & (K Units)
Table 69. China Active Transdermal Drug Delivery Device Sales Market Share by Type (2022-2027)
Table 70. China Active Transdermal Drug Delivery Device Sales by Application (2016-2021) & (K Units)
Table 71. China Active Transdermal Drug Delivery Device Sales Market Share by Application (2016-2021)
Table 72. China Active Transdermal Drug Delivery Device Sales by Application (2022-2027) & (K Units)
Table 73. China Active Transdermal Drug Delivery Device Sales Market Share by Application (2022-2027)
Table 74. Japan Active Transdermal Drug Delivery Device Sales (K Units) by Company (2016-2021)
Table 75. Japan Active Transdermal Drug Delivery Device Sales Market Share by Company (2016-2021)
Table 76. Japan Active Transdermal Drug Delivery Device Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Active Transdermal Drug Delivery Device Revenue Market Share by Company (2016-2021)
Table 78. Japan Active Transdermal Drug Delivery Device Sales by Type (2016-2021) & (K Units)
Table 79. Japan Active Transdermal Drug Delivery Device Sales Market Share by Type (2016-2021)
Table 80. Japan Active Transdermal Drug Delivery Device Sales by Type (2022-2027) & (K Units)
Table 81. Japan Active Transdermal Drug Delivery Device Sales Market Share by Type (2022-2027)
Table 82. Japan Active Transdermal Drug Delivery Device Sales by Application (2016-2021) & (K Units)
Table 83. Japan Active Transdermal Drug Delivery Device Sales Market Share by Application (2016-2021)
Table 84. Japan Active Transdermal Drug Delivery Device Sales by Application (2022-2027) & (K Units)
Table 85. Japan Active Transdermal Drug Delivery Device Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Active Transdermal Drug Delivery Device Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Active Transdermal Drug Delivery Device Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Active Transdermal Drug Delivery Device Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Active Transdermal Drug Delivery Device Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Active Transdermal Drug Delivery Device Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Active Transdermal Drug Delivery Device Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Active Transdermal Drug Delivery Device Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Active Transdermal Drug Delivery Device Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Active Transdermal Drug Delivery Device Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Active Transdermal Drug Delivery Device Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Active Transdermal Drug Delivery Device Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Active Transdermal Drug Delivery Device Sales Market Share by Application (2022-2027)
Table 98. India Active Transdermal Drug Delivery Device Sales (K Units) by Company (2016-2021)
Table 99. India Active Transdermal Drug Delivery Device Sales Market Share by Company (2016-2021)
Table 100. India Active Transdermal Drug Delivery Device Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Active Transdermal Drug Delivery Device Revenue Market Share by Company (2016-2021)
Table 102. India Active Transdermal Drug Delivery Device Sales by Type (2016-2021) & (K Units)
Table 103. India Active Transdermal Drug Delivery Device Sales Market Share by Type (2016-2021)
Table 104. India Active Transdermal Drug Delivery Device Sales by Type (2022-2027) & (K Units)
Table 105. India Active Transdermal Drug Delivery Device Sales Market Share by Type (2022-2027)
Table 106. India Active Transdermal Drug Delivery Device Sales by Application (2016-2021) & (K Units)
Table 107. India Active Transdermal Drug Delivery Device Sales Market Share by Application (2016-2021)
Table 108. India Active Transdermal Drug Delivery Device Sales by Application (2022-2027) & (K Units)
Table 109. India Active Transdermal Drug Delivery Device Sales Market Share by Application (2022-2027)
Table 110. Novartis AG Corporation Information
Table 111. Novartis AG Description and Business Overview
Table 112. Novartis AG Active Transdermal Drug Delivery Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Novartis AG Active Transdermal Drug Delivery Device Product
Table 114. Novartis AG Recent Development
Table 115. Noven Pharmaceuticals, Inc. Corporation Information
Table 116. Noven Pharmaceuticals, Inc. Description and Business Overview
Table 117. Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Product
Table 119. Noven Pharmaceuticals, Inc. Recent Development
Table 120. Transdermal Corp. Corporation Information
Table 121. Transdermal Corp. Description and Business Overview
Table 122. Transdermal Corp. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Transdermal Corp. Active Transdermal Drug Delivery Device Product
Table 124. Transdermal Corp. Recent Development
Table 125. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Corporation Information
Table 126. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Description and Business Overview
Table 127. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Product
Table 129. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Recent Development
Table 130. Mylan N.V. Corporation Information
Table 131. Mylan N.V. Description and Business Overview
Table 132. Mylan N.V. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Mylan N.V. Active Transdermal Drug Delivery Device Product
Table 134. Mylan N.V. Recent Development
Table 135. 3M Corporation Information
Table 136. 3M Description and Business Overview
Table 137. 3M Active Transdermal Drug Delivery Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. 3M Active Transdermal Drug Delivery Device Product
Table 139. 3M Recent Development
Table 140. Actavis, Inc. Corporation Information
Table 141. Actavis, Inc. Description and Business Overview
Table 142. Actavis, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Actavis, Inc. Active Transdermal Drug Delivery Device Product
Table 144. Actavis, Inc. Recent Development
Table 145. Bayer AG Corporation Information
Table 146. Bayer AG Active Transdermal Drug Delivery Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Bayer AG Description and Business Overview
Table 148. Bayer AG Active Transdermal Drug Delivery Device Product
Table 149. Bayer AG Recent Development
Table 150. Boehringer Ingelheim GmbH Corporation Information
Table 151. Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Boehringer Ingelheim GmbH Description and Business Overview
Table 153. Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Product
Table 154. Boehringer Ingelheim GmbH Recent Development
Table 155. Corium International, Inc. Corporation Information
Table 156. Corium International, Inc. Description and Business Overview
Table 157. Corium International, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. Corium International, Inc. Active Transdermal Drug Delivery Device Product
Table 159. Corium International, Inc. Recent Development
Table 160. Echo Therapeutics, Inc. Corporation Information
Table 161. Echo Therapeutics, Inc. Description and Business Overview
Table 162. Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 163. Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Product
Table 164. Echo Therapeutics, Inc. Recent Development
Table 165. GlaxoSmithKline plc Corporation Information
Table 166. GlaxoSmithKline plc Description and Business Overview
Table 167. GlaxoSmithKline plc Active Transdermal Drug Delivery Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 168. GlaxoSmithKline plc Active Transdermal Drug Delivery Device Product
Table 169. GlaxoSmithKline plc Recent Development
Table 170. Production Base and Market Concentration Rate of Raw Material
Table 171. Key Suppliers of Raw Materials
Table 172. Active Transdermal Drug Delivery Device Distributors List
Table 173. Active Transdermal Drug Delivery Device Customers List
Table 174. Active Transdermal Drug Delivery Device Market Trends
Table 175. Active Transdermal Drug Delivery Device Market Drivers
Table 176. Active Transdermal Drug Delivery Device Market Challenges
Table 177. Active Transdermal Drug Delivery Device Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Active Transdermal Drug Delivery Device Product Picture
Figure 2. Global Active Transdermal Drug Delivery Device Sales Market Share by Type in 2021 & 2027
Figure 3. Patches Product Picture
Figure 4. Gels Product Picture
Figure 5. Global Active Transdermal Drug Delivery Device Sales Market Share by Application in 2021 & 2027
Figure 6. Clinic Examples
Figure 7. Hospital Examples
Figure 8. Home Use Examples
Figure 9. Global Active Transdermal Drug Delivery Device Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Active Transdermal Drug Delivery Device Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Active Transdermal Drug Delivery Device Sales (K Units) Growth Rate (2016-2027)
Figure 12. Global Active Transdermal Drug Delivery Device Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 13. Global Active Transdermal Drug Delivery Device Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Active Transdermal Drug Delivery Device Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Active Transdermal Drug Delivery Device Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Active Transdermal Drug Delivery Device Sales (K Units) Growth Rate (2016-2027)
Figure 17. Europe Active Transdermal Drug Delivery Device Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Active Transdermal Drug Delivery Device Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Active Transdermal Drug Delivery Device Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Active Transdermal Drug Delivery Device Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Active Transdermal Drug Delivery Device Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Active Transdermal Drug Delivery Device Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Active Transdermal Drug Delivery Device Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Active Transdermal Drug Delivery Device Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Active Transdermal Drug Delivery Device Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Active Transdermal Drug Delivery Device Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Active Transdermal Drug Delivery Device Players Market Share by Revenue in Active Transdermal Drug Delivery Device: 2016 & 2020
Figure 28. Active Transdermal Drug Delivery Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Active Transdermal Drug Delivery Device Revenue Share by Type (2016-2021)
Figure 30. Global Active Transdermal Drug Delivery Device Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Active Transdermal Drug Delivery Device Revenue Share by Application (2016-2021)
Figure 32. Global Active Transdermal Drug Delivery Device Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Active Transdermal Drug Delivery Device Sales Market Share by Type in 2020
Figure 34. North America Active Transdermal Drug Delivery Device Sales Market Share by Application in 2020
Figure 35. Europe Active Transdermal Drug Delivery Device Sales Market Share by Type in 2020
Figure 36. Europe Active Transdermal Drug Delivery Device Sales Market Share by Application in 2020
Figure 37. China Active Transdermal Drug Delivery Device Sales Market Share by Type in 2020
Figure 38. China Active Transdermal Drug Delivery Device Sales Market Share by Application in 2020
Figure 39. Japan Active Transdermal Drug Delivery Device Sales Market Share by Type in 2020
Figure 40. Japan Active Transdermal Drug Delivery Device Sales Market Share by Application in 2020
Figure 41. Southeast Asia Active Transdermal Drug Delivery Device Sales Market Share by Type in 2020
Figure 42. Southeast Asia Active Transdermal Drug Delivery Device Sales Market Share by Application in 2020
Figure 43. India Active Transdermal Drug Delivery Device Sales Market Share by Type in 2020
Figure 44. India Active Transdermal Drug Delivery Device Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Active Transdermal Drug Delivery Device
Figure 47. Manufacturing Process Analysis of Active Transdermal Drug Delivery Device
Figure 48. Active Transdermal Drug Delivery Device Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed